Results for:(182 found)
Apr 2, 2012 11:02AM on Top StocksBy Melly Alazraki

The biotech has brighter prospects than its valuation suggests.

Apr 2, 2012 9:59AM on Top StocksBy

The generics drugmaker plans to tackle AstraZeneca's blockbuster antipsychotic drug Seroquel next.

Mar 15, 2012 1:38PM on Top StocksBy Melly Alazraki

Unlike many Americans, Bill Weldon has nothing to fear from retirement.

Tags: JNJ
Mar 9, 2012 12:02PM on Top StocksBy MSN Money Partner

Homebuilders are upgraded at Credit Suisse, and Herbalife is initiated with an 'overweight.'

Mar 9, 2012 10:38AM on Top StocksBy TheStockAdvisors

Based on historic patterns of yield, here are ten undervalued blue chips for growth and income.

Mar 8, 2012 2:59PM on Top StocksBy Melly Alazraki

Johnson & Johnson's recently approved Zytiga continues to score at the expense of Dendreon's Provenge.

Feb 28, 2012 4:48PM on Top StocksBy Motley Fool Pick of the Day

Pre-announcing sales didn't lessen the angst.

Feb 17, 2012 2:37PM on Top StocksBy Kim Peterson

This time, the problem isn't with Tylenol but with its delivery method.

Tags: JNJ



Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.